Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the multiple outcomes of Raloxifene Evaluation trial
- 30 September 2003
- Vol. 33 (3) , 293-300
- https://doi.org/10.1016/s8756-3282(03)00200-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical TrialJournal of Clinical Endocrinology & Metabolism, 2002
- Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene TherapyJournal of Bone and Mineral Research, 2002
- Prevalent Vertebral Deformities Predict Hip Fractures and New Vertebral Deformities but Not Wrist FracturesJournal of Bone and Mineral Research, 1999
- Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fracturesBMJ, 1996
- Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessmentJournal of Clinical Endocrinology & Metabolism, 1995
- The association between age and bone mineral density in men and women aged 55 years and over: The Rotterdam StudyBone and Mineral, 1994
- Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis.BMJ, 1993
- Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assayJournal of Bone and Mineral Research, 1992
- Contribution of vertebral deformities to chronic back pain and disabilityJournal of Bone and Mineral Research, 1992
- Involutional OsteoporosisNew England Journal of Medicine, 1986